<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01103921</url>
  </required_header>
  <id_info>
    <org_study_id>200715772</org_study_id>
    <secondary_id>R01HL091333</secondary_id>
    <secondary_id>R01HL107256</secondary_id>
    <nct_id>NCT01103921</nct_id>
  </id_info>
  <brief_title>The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks</brief_title>
  <acronym>DRS</acronym>
  <official_title>Effects of 2-weeks Fructose &amp; HFCS Consumption on Dyslipidemia &amp; Insulin Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effects of consumption of sugar-sweetened
      beverages on blood triglycerides and cholesterol, cholesterol concentrations, and the body's
      sensitivity to insulin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed as a prospective, blinded diet intervention study during which the
      participants consume either fructose- or HFCS-sweetened beverages (providing 10%, 17.5% or
      25% of energy) with meals. In addition, there will be two control groups, with one group
      consuming 0% sugar beverages sweetened with sucralose and the other consuming
      glucose-sweetened beverages at 25% of energy requirement. Experimental procedures, including
      24-hour serial blood sampling, post-heparin infusions, gluteal biopsies, Magnetic Resonance
      Imaging of the liver and the abdomen, and Oral Glucose Tolerance and Disposal Tests, are
      performed during baseline and at the end of a 2-week intervention period at the UC Davis
      Clinical and Translational Science Center (CTSC) Clinical Research Center (CCRC). During the
      inpatient periods, subjects are served energy balanced diets. The diets provide 15% of energy
      as protein, 30% as fat, and 55% as carbohydrate. During baseline testing, the carbohydrate
      content consists primarily of complex carbohydrate (&gt;97%). During intervention the 55%
      carbohydrate will consist of 10% sugar/45% complex, 17.5% sugar/37.5% complex, or 25%
      sugar/30% complex depending on the diet group to which the subject is assigned. During the
      outpatient intervention periods, the subjects reside at home and are provided with fructose-
      or HFCS -sweetened beverages that are consumed with each meal along with a self-selected ad
      libitum (usual) diet.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24-hour triglyceride area under the curve</measure>
    <time_frame>Baseline and 2-week intervention</time_frame>
    <description>32 serial blood samples are collected over a 24 hour period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity index</measure>
    <time_frame>Baseline and 2-week intervention</time_frame>
    <description>Insulin sensitivity is assessed using the deuterated glucose disposal method.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">214</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Insulin Resistance</condition>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>Glucose</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fructose</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>High-Fructose Corn Syrup</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspartame</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No sugar</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose</intervention_name>
    <description>25% dose at 2-week intervention assigned to subjects.</description>
    <arm_group_label>Glucose</arm_group_label>
    <other_name>Sugar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fructose</intervention_name>
    <description>25%, 17.5%, or 10% dose at 2-week intervention assigned to subjects.</description>
    <arm_group_label>Fructose</arm_group_label>
    <other_name>Sugar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-Fructose Corn Syrup</intervention_name>
    <description>25%, 17.5%, or 10% dose at 2-week intervention assigned to subjects.</description>
    <arm_group_label>High-Fructose Corn Syrup</arm_group_label>
    <other_name>HFCS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No sugar (Aspartame)</intervention_name>
    <description>0% dose at 2-week intervention assigned to subjects.</description>
    <arm_group_label>Aspartame</arm_group_label>
    <other_name>Non-caloric sweetener</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index between 18-35

          -  Self report of stable body weight during the past six months

        Exclusion Criteria:

          -  Diabetes Mellitus

          -  Evidence of liver disorder

          -  Evidence of kidney disorder

          -  Evidence of thyroid disorder

          -  Systolic blood pressure consistently over 160mmHg or diastolic blood pressure over
             900mmHg

          -  Triglycerides &gt; 400mg/dl

          -  LDL-C &gt; 240mg/dl

          -  Hemoglobin &lt; 8.5 g/dl

          -  Current, prior (within 2 months), or anticipated use of any hypolipidemic or
             anti-diabetic agents

          -  Use of Selective Serotonin Reuptake Inhibitors and anti-hypertensive medications

          -  Any other condition that, in the opinion of the investigators, would put subject at
             risk

          -  Strenuous exerciser

          -  Pregnant or lactating women

          -  Smoker

          -  Diet exclusions: food allergies, special dietary restrictions, habitual ingest of &gt;2
             alcoholic beverages/day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter J Havel, D.V.M</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kimber L Stanhope, Ph.D, R.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2010</study_first_submitted>
  <study_first_submitted_qc>April 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2010</study_first_posted>
  <last_update_submitted>May 25, 2017</last_update_submitted>
  <last_update_submitted_qc>May 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sugar</keyword>
  <keyword>fructose</keyword>
  <keyword>glucose</keyword>
  <keyword>HFCS</keyword>
  <keyword>metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

